Amprius Technologies, Inc.
NYSE:AMPXElectrical Equipment & Parts
+$0.58 today
- Market cap
- $986.91M
- Beta
- 2.13
- P/E (TTM)
- -53.7
- EPS (TTM)
- -$0.29
Volume 6.59M
Average 8.61M
AMPX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Amprius Technologies, Inc.NYSE: AMPX
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $3.8M rose 89.7% year over year, ahead of the +44.6% change in trailing-twelve-month research & development. Sequentially, it rose 37.8% from the prior quarter. Over 3 fiscal years it compounded at +66.9% a year.
Context
- Research & development amounted to 12.9% of revenue in FY2025, down 17.5 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +89.7% holds above the trailing-twelve-month pace of +44.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 9.43M USD
- Year-over-year change
- +28.4%
- 4-year CAGR
- +59.7%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.43M | +28.4% |
| FY2024 | 2024-12-31 | 7.34M | +99.7% |
| FY2023 | 2023-12-31 | 3.68M | +81.1% |
| FY2022 | 2022-12-31 | 2.03M | +40.0% |
| FY2021 | 2021-12-31 | 1.45M | — |
Research & Development vs competitors
How AMPX compares with its peers on the latest reported figures
- AMPX's LTM Mar 2026 research & development of $11.23M is the 6th highest of the 10 companies compared; the peer median is $14.09M.
- Its year-over-year change of +44.6% is the highest of 6, against a peer median of -8.3%.
- Research & development amounts to 12.4% of revenue for AMPX, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $110.07M | +8.3% | +23.9% | 320.7% | |
| LTM Mar 2026 | $34.67M | -8.3% | -7.8% | 9.3% | |
| LTM Mar 2026 | $31.9M | -0.3% | -2.1% | 1.1% | |
| LTM Mar 2026 | $16.22M | — | — | 9.7% | |
| LTM Jun 2026 | $14.09M | -44.6% | -29.5% | 0.8% | |
| LTM Mar 2026 | $11.23M | +44.6% | +66.9% | 12.4% | |
| LTM Jun 2026 | $11M | — | — | 0.5% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AMPX) | $14.09M | -8.3% | -4.9% | 0.8% | |
Competitors are the stored peer set for AMPX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.77M | 4.41M | 8.79M | 24.17M | 73.01M |
| Cost of Revenue | 7.1M | 9.85M | 23.73M | 42.5M | 64.75M |
| Gross Profit | (4.33M) | (5.44M) | (14.94M) | (18.33M) | 8.26M |
| Gross Margin | -156.2% | -123.4% | -169.9% | -75.8% | 11.3% |
| Research & Development | 1.45M | 2.03M | 3.68M | 7.34M | 9.43M |
| Selling, General & Admin | 4.84M | 10.57M | 20.36M | 18.73M | 22.96M |
| Operating Expenses | 6.29M | 12.6M | 23.77M | 26.07M | 54.91M |
| Depreciation & Amortization | 1.44M | 2.1M | 1.81M | 5.05M | 4.37M |
| EBITDA | (8.46M) | (15.24M) | (34.97M) | (39.62M) | (39.66M) |
| EBITDA Margin | -305.0% | -345.6% | -397.8% | -163.9% | -54.3% |
| Operating Income | (10.62M) | (18.04M) | (38.71M) | (44.4M) | (46.65M) |
| Operating Margin | -383.2% | -409.2% | -440.3% | -183.7% | -63.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 727K | 709K | 1.93M | (271K) | 2.62M |
| Income Before Tax | (9.9M) | (17.33M) | (36.78M) | (44.67M) | (44.02M) |
| Pre-Tax Margin | -357.0% | -393.1% | -418.3% | -184.8% | -60.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (9.9M) | (17.33M) | (36.78M) | (44.67M) | (44.02M) |
| Net Margin | -357.0% | -393.1% | -418.3% | -184.8% | -60.3% |
| EPS (Basic) | (0.10) | (0.20) | (0.43) | (0.45) | (0.35) |
| EPS (Diluted) | (0.10) | (0.20) | (0.43) | (0.45) | (0.35) |
| Weighted Avg Shares | 100.99M | 84.61M | 86.2M | 101.87M | 124.64M |
| Weighted Avg Shares (Diluted) | 100.99M | 84.61M | 86.2M | 101.87M | 124.64M |
Amprius Technologies, Inc.
NYSE:AMPX
Intrinsic Alpha fair value
Locked
Current Price
$6.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.